When companies are testing a medical device’s bioburden – a measure of how much and what types of viable organisms are in or on it after manufacturing – they might question how exact their results should be or what to do if the numbers seem off.
Health care leaders who fail to proactively communicate or share decision-making as it relates to sterile processing (SP) operations can lead to culture of divisiveness, lack of trust and a loss of confidence in SP processes.Â
Annual report offers quantitative and qualitative analysis, guidance for sustainable quality improvement (Deerfield, Ill.) Nov. 29, 2023 – Today, the Accreditation Association for Ambulatory Health Care (AAAHC) releases its 2023 AAAHC Quality Roadmap, a comprehensive...
TOPIC:Â Senhance Surgical System by Asensus Surgical:Â Class I Recall – Due to Malfunctions with Unintended Movement of the Robotically-Assisted Surgical Device AUDIENCE:Â Patient, Health Professional, OB/GYN ISSUE:Â Asensus Surgical is recalling the Senhance...